Activation of mesocorticolimbic reward circuits for assessment of relief of ongoing pain: a potential biomarker of efficacy.
about
A Trigger for Opioid Misuse: Chronic Pain and Stress Dysregulate the Mesolimbic Pathway and Kappa Opioid SystemBrain Circuits Encoding Reward from Pain ReliefIdentification of a novel spinal nociceptive-motor gate control for Aδ pain stimuli in rats.Cannabidiol Is a Potential Therapeutic for the Affective-Motivational Dimension of Incision Pain in Rats.Reward and motivation in pain and pain reliefEndogenous opioid activity in the anterior cingulate cortex is required for relief of pain.RGS9-2 modulates sensory and mood related symptoms of neuropathic pain.Gabapentin alleviates affective pain after traumatic nerve injury.Behavioral and neurochemical analysis of ongoing bone cancer pain in rats.The affective dimension of pain as a risk factor for drug and alcohol addiction.Evaluation of a Postoperative Pain-Like State on Motivated Behavior in Rats: Effects of Plantar Incision on Progressive-Ratio Food-Maintained RespondingThe Analgesic Effects of (5R,6R)6-(3-Propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1] Octane on a Mouse Model of Neuropathic Pain.Does the kappa opioid receptor system contribute to pain aversion?Mesolimbic dopamine signaling in acute and chronic pain: implications for motivation, analgesia, and addiction.The Anti-Allodynic Gabapentinoids: Myths, Paradoxes, and Acute Effects.Modulation of pain, nociception, and analgesia by the brain reward center.Multiple sites and actions of gabapentin-induced relief of ongoing experimental neuropathic pain.Effects of Treadmill Exercise on Advanced Osteoarthritis Pain in Rats.Sustained relief of ongoing experimental neuropathic pain by a CRMP2 peptide aptamer with low abuse potential.Calcium channel modulation as a target in chronic pain control.A critical evaluation of validity and utility of translational imaging in pain and analgesia: Utilizing functional imaging to enhance the process.Subliminal (latent) processing of pain and its evolution to conscious awareness.Emotion dysregulation as a transdiagnostic mechanism of opioid misuse and suicidality among chronic pain patients.CRMP2 and voltage-gated ion channels: potential roles in neuropathic painInhibition of the Prefrontal Projection to the Nucleus Accumbens Enhances Pain Sensitivity and AffectForebrain medial septum sustains experimental neuropathic pain
P2860
Q28074686-F3B9BECF-93AF-4CE3-B919-6ED2130F187EQ28080596-04CB2DE6-B60D-4A95-AA26-504DFE132D79Q33798019-C4C83737-83D6-45B6-AF9C-62DC8147C6FBQ33819645-06D029F6-9A61-4828-B8FB-AFC0192227F4Q34993445-1C2709D4-FA3B-4ED2-8115-F4411D35003FQ35572558-DE54B6A1-04A9-438B-9BF2-FC746019F7FAQ35695071-CA26CC83-632E-439D-BA58-6EEC6C62F19CQ35776426-33057231-6469-4C17-B8C4-05EC24E8131EQ36083409-2876AF5C-7DFB-4015-AFE5-D1BCB3F6A690Q36236950-CBCFD98E-2CEE-4FA5-A46E-0A398D8A89CBQ36470177-05E27F68-69F1-4D86-98F0-907D970DE347Q37722571-BB0EC244-DDA1-4F93-8A4F-6F87353EE119Q38276410-32B7A89E-EDA8-48DE-9FD4-8406C6DCFB91Q38707324-671D2E29-DB4F-4D85-AE28-804D8CED364AQ38818781-B4FEA969-AE48-465D-A052-1B7272A4A63EQ38836955-36F925AD-BF2D-4A4D-AE4B-3E344171FD15Q39150998-C2C8E668-4694-4FD3-B82C-DD94611E8A34Q39158161-ED4FAE35-06FE-4596-A167-2FF1C253B69BQ39168504-8BF682B3-215A-482E-94FC-CC29E82C367CQ39188300-77CCC973-135D-43AD-8258-7790D199A276Q48154527-37B5AD71-20A0-4C21-BE70-5FB51F014170Q55253332-FE3454CE-D969-43BF-BB36-E8D673F4CA01Q55487569-20623D08-BD5B-48A5-8F98-AEEB90D54BE3Q58582878-0545BF71-A3CE-4184-8F28-ECC12AF1F687Q58785862-192D7B44-D56C-4A3E-895A-969D02E6EC94Q58796078-AA7173E8-5F0F-4332-804C-6B19F2BF92A8
P2860
Activation of mesocorticolimbic reward circuits for assessment of relief of ongoing pain: a potential biomarker of efficacy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Activation of mesocorticolimbi ...... tential biomarker of efficacy.
@en
Activation of mesocorticolimbi ...... tential biomarker of efficacy.
@nl
type
label
Activation of mesocorticolimbi ...... tential biomarker of efficacy.
@en
Activation of mesocorticolimbi ...... tential biomarker of efficacy.
@nl
prefLabel
Activation of mesocorticolimbi ...... tential biomarker of efficacy.
@en
Activation of mesocorticolimbi ...... tential biomarker of efficacy.
@nl
P2093
P2860
P1433
P1476
Activation of mesocorticolimbi ...... tential biomarker of efficacy.
@en
P2093
Amol Patwardhan
Chaoling Qu
David Borsook
Edita Navratilova
Frank Porreca
Jennifer Y Xie
Lino Becerra
Michael H Ossipov
P2860
P304
P356
10.1016/J.PAIN.2014.05.018
P407
P577
2014-05-23T00:00:00Z